Bionet-asia Co., Ltd.

This study checked the safety of the VacPertagen whooping cough vaccine after it was already approved for use in Thailand. Over 5,400 people, including pregnant women, were monitored for side effects. The goal was to make sure the vaccine is safe for the general population.

This study tested a new whooping cough vaccine (DTaPgen) in 290 healthy toddlers aged 15 to 36 months. The goal was to see if it works as well as a current licensed vaccine. Researchers measured immune response and checked for side effects after the booster shot.

This study checked the safety of the TdaP vaccine Boostagen® after it was already approved in Thailand. Over 10,000 people who got the vaccine in regular doctor visits were watched for side effects. The goal was to see how safe the vaccine is in a large, real-world group, includi…